BPG is committed to discovery and dissemination of knowledge
Prospective Study
Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Apr 15, 2026; 18(4): 116949
Published online Apr 15, 2026. doi: 10.4251/wjgo.v18.i4.116949
Table 1 Effects of upper gastrointestinal endoscopic screening in multivariable analysis on the cessation of cigarette smoking, alcohol drinking and unhealthy dietary habits
VariableCessation of cigarette smoking (n = 5600)1
Cessation of alcohol drinking (n = 4949)2
Reduction of unhealthy dietary habit (n = 24629)3
Outcome events/total (%)
Adjusted OR (95%CI)
Outcome events/total (%)
Adjusted OR (95%CI)
Outcome events/total (%)
Adjusted OR (95%CI)
Screening
Control arm681/2815 (24.19)Reference960/2497 (38.45)Reference5059/12790 (39.55)Reference
Screening arm775/2785 (27.83)1.20 (1.06-1.36)1114/2452 (45.43)1.33 (1.19-1.50)4870/11839 (41.14)1.07 (1.02-1.13)
Table 2 Subgroup analysis of the uptake of upper gastrointestinal endoscopic screening for cessation of cigarette smoking, alcohol drinking and unhealthy dietary habits
VariableCessation of cigarette smoking (n = 5600)1
Cessation of alcohol drinking (n = 4949)2
Reduction of unhealthy dietary habit (n = 24629)3
Outcome events/total (%)
Adjusted OR (95%CI)
Outcome events/total (%)
Adjusted OR (95%CI)
Outcome events/total (%)
Adjusted OR (95%CI)
Screening status
Control arm681/2815 (24.19)Reference960/2497 (38.45)Reference5059/12790 (39.55)Reference
Subjects decline UGI endoscopy20/88 (22.73)1.09 (0.65-1.83)33/85 (38.82)1.18 (0.75-1.87)156/389 (40.10)1.04 (0.85-1.28)
Subjects complete UGI endoscopy but without biopsy663/2465 (26.90)1.15 (1.01-1.31)974/2145 (45.41)1.35 (1.19-1.52)4314/10591 (40.73)1.06 (1.00-1.11)
Subjects complete UGI endoscopy with biopsy92/232 (39.66)1.77 (1.32-2.35)107/222 (48.20)1.27 (0.96-1.69)400/859 (46.57)1.31 (1.14-1.50)
Table 3 Effects of upper gastrointestinal endoscopic screening on cessation of cigarette smoking, alcohol drinking and unhealthy dietary habit, stratified by sex, baseline age and baseline gastrointestinal symptoms score
Stratified variableCessation of cigarette smoking (n = 5600)1
Cessation of alcohol drinking (n = 4949)2
Reduction of unhealthy dietary habit (n = 24629)3
Outcome events/total (%)
Adjusted
OR (95%CI)
P value
Outcome events/total (%)
Adjusted
OR (95%CI)
P value
Outcome events/total (%)
Adjusted
OR (95%CI)
P value
Sex
Female48/94 (51.06)1.50 (0.58-3.85)0.39942/63 (66.67)1.56 (0.37-6.53)0.5465550/13255 (41.87)1.12 (1.04-1.20)0.002
Male1408/5506 (25.57)1.19 (1.05-1.35)0.0072032/4886 (41.59)1.32 (1.17-1.49)< 0.0014379/11374 (38.50)1.02 (0.94-1.10)0.617
Interaction40.5570.1810.033
Baseline age
< 60700/3241 (21.60)1.16 (0.98-1.38)0.0891108/3026 (36.62)1.16 (0.99-1.35) 0.0615752/14515 (39.63)1.03 (0.96-1.10)0.451
≥ 60756/2359 (32.05)1.23 (1.03-1.47)0.024966/1923 (50.23)1.66 (1.38-2)< 0.0014177/10114 (41.30)1.14 (1.05-1.24)0.001
Interaction40.5890.0040.130
Baseline gastrointestinal symptoms score
0795/3092 (25.71)1.16 (0.98-1.37)0.087997/2586 (38.55)1.41 (1.20-1.67)< 0.0015322/13578 (39.20)1.08 (1.01-1.16)0.029
≥ 1661/2508 (26.36)1.25 (1.04-1.51)0.0181077/2363 (45.58)1.26 (1.07-1.49)0.0074607/11051 (41.69)1.06 (0.98-1.14)0.158
Interaction40.4880.4360.662